Transglutaminase 2: a novel therapeutic target for idiopathic pulmonary fibrosis using selective small molecule inhibitors

This study investigates the effects of a site-directed TG2-selective inhibitor on the lung myofibroblast phenotype and ECM deposition to elucidate TG2 as a novel therapeutic target in idiopathic pulmonary fibrosis (IPF)—an incurable progressive fibrotic disease. IPF fibroblasts showed increased expr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Amino Acids
Hlavní autoři: Fell, Shaun, Wang, Zhuo, Blanchard, Andy, Nanthakumar, Carmel, Griffin, Martin
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Vienna 2021
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7910249/
https://ncbi.nlm.nih.gov/pubmed/33474654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00726-020-02938-w
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky